ResearcherArmy Medical UniversityNo recent work listed
Lu Zheng
Matched on ORCID iD 0000-0002-5563-4348; OpenAlex author ID A5100668765. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 3
- Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. Co-author DOI 10.3389/fonc.2023.1167144↗
- Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p… Co-author DOI 10.21037/jgo-20-533↗
- COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma. Last author DOI 10.1002/mc.22520↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xiaobing Huang · 3 shared papers, 2017–2023 · strength 0.40
- Paper Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. DOI 10.3389/fonc.2023.1167144↗
- Paper Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells… DOI 10.21037/jgo-20-533↗
- Paper COMMD7 functions as molecular target in pancreatic ductal adenocarcinoma. DOI 10.1002/mc.22520↗
- Yichen Tang · 2 shared papers, 2021–2023 · strength 0.32
- Paper Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing. DOI 10.3389/fonc.2023.1167144↗
- Paper Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells… DOI 10.21037/jgo-20-533↗
- Nan You · 2 shared papers, 2017–2023 · strength 0.24
- Yonggang He · 1 shared paper, 2023 · strength 0.17
- Yonggang He · 1 shared paper, 2021 · strength 0.16
- Liang Wang · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.